Flna Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
FLNA (Filamin A) encodes a massive actin-binding protein that forms orthogonal networks and links actin filaments to membrane glycoproteins. It serves as a scaffold for numerous proteins involved in cell signaling, mechanotransduction, and neuronal function.
| FLNA - Filamin A |
|---|
| Gene Symbol | FLNA |
| Full Name | Filamin A |
| Chromosomal Location | Xq28 |
| NCBI Gene ID | 2316 |
| OMIM | 300017 |
| Ensembl ID | ENSG00000196924 |
| UniProt | P21333 |
| Associated Diseases | Periventricular Heterotopia, Frontometaphyseal Dysplasia, X-linked Parkinsonism |
FLNA (Filamin A) is a 280 kDa actin-binding protein that serves as a critical scaffold for protein-protein interactions in eukaryotic cells. The protein forms flexible V-shaped dimers that connect actin filaments into orthogonal networks, providing mechanical stability to cells and tissues. In the nervous system, FLNA is essential for neuronal migration, synaptic formation, and plasticity.
FLNA is a large (280 kDa) actin-crosslinking protein composed of:
- N-terminal actin-binding domain: Binds to F-actin
- 24 repeat repeats: Each containing two calponin homology (CH) domains that serve as protein interaction surfaces
- C-terminal dimerization domain: Enables orthogonal network formation
In neurons, FLNA is enriched in dendritic spines and postsynaptic densities where it:
- Synaptic scaffold: Anchors NMDA receptor subunits (GRIN1, GRIN2B) and AMPAR subunits (GRIA1, GRIA2)
- Cytoskeletal link: Links membrane proteins to the actin cytoskeleton
- Spine morphogenesis: Coordinates spine formation and maintenance
- Synaptic plasticity: Participates in LTP and LTD through AMPA receptor trafficking
- Mechanotransduction: Coordinates signaling downstream of mechanosensitive channels
- Signaling hub: Binds to numerous signaling proteins including small GTPases, kinases, and phosphatases
- Cell migration and adhesion
- Mechanical stability of blood vessels
- Organ development
- Cell division and cytokinesis
FLNA contains 24 immunoglobulin-like repeats (repeats 1-23 and hinge 1-2):
| Region |
Residues |
Function |
| Actin-binding domain |
1-274 |
N-terminal F-actin binding |
| Repeats 1-9 |
275-1008 |
Protein interactions (integrins, GPIbα) |
| Hinge 1 |
1009-1137 |
Proteolytic cleavage site |
| Repeats 10-15 |
1138-1749 |
Protein interactions (Rho GTPases) |
| Hinge 2 |
1750-1877 |
Flexibility, cleavage site |
| Repeats 16-23 |
1878-2387 |
Protein interactions |
| C-terminal |
2388-2647 |
Dimerization |
FLNA is widely expressed throughout the brain with particularly high levels in:
- Cerebral cortex: Layers II-VI, pyramidal neurons
- Hippocampus: CA1-CA3 pyramidal neurons, dentate gyrus granule cells
- Basal ganglia: Striatal medium spiny neurons
- Cerebellum: Purkinje cells
- Spinal cord: Motor neurons
- Substantia nigra: Dopaminergic neurons
Expression data from Allen Brain Atlas confirms widespread neuronal expression with enrichment in regions involved in neurodegenerative processes.
- X-linked dominant mutations in FLNA cause abnormal neuronal migration
- Characterized by nodules of gray matter lining the ventricles
- Often associated with epilepsy and developmental delays
- Female carriers may have milder phenotypes due to X-inactivation
- FLNA mutations cause this skeletal dysplasia
- Characterized by megaencephaly, facial dysmorphism, skeletal anomalies
- FLNA has been implicated in PD pathogenesis through interactions with LRRK2
- FLNA interacts with leucine-rich repeat kinase 2 (LRRK2), a major PD gene product
- FLNA knockout in mice leads to dopaminergic neuron loss
- Variants in FLNA may modify PD risk and progression
- X-linked FLNA mutations associated with parkinsonism in some families
- FLNA in amyloid-beta processing and toxicity
- Synaptic FLNA loss in AD brains
- Role in tau phosphorylation and spread
- FLNA in traumatic brain injury response
- May influence recovery and plasticity
FLNA participates in multiple signaling pathways:
- LRRK2 signaling: Direct interaction with LRRK2 PD mutations affect this interaction
- Rho GTPase pathways: Binds to Rac1, Cdc42, RhoA effectors
- Integrin signaling: Links integrins to actin cytoskeleton
- NMDA receptor trafficking: Anchors NMDA receptors at synapses
- AMPA receptor cycling: Regulates AMPA receptor endocytosis/exocytosis
- MAPK/ERK signaling: Activates downstream kinases
- Calcium signaling: Modulates calcium-dependent processes
| Approach |
Target |
Development Stage |
| Small molecule inhibitors |
FLNA-actin binding |
Preclinical |
| Peptide disrupters |
Protein-protein interactions |
Research |
| Gene therapy |
FLNA restoration |
Theoretical |
Therapeutic challenges:
- Large protein size limits traditional drug design
- Essential functions create narrow therapeutic window
- Tissue-specific targeting needed
- FLNA knockout mice: Embryonic lethal in males, viability in females
- Conditional knockouts: Brain-specific deletion shows neuronal migration defects
- knock-in models: Expressing patient-derived FLNA mutations
- LRRK2-FLNA double mutants: Synergistic effects on dopaminergic neurons
- FLNA-LRRK2 interaction: Therapeutic modulation
- Synaptic FLNA dynamics: Live imaging in neurons
- Biomarkers: FLNA fragments as markers of neuronal injury
- Structure-based drug design: Small molecule targeting
- Gene therapy: AAV delivery of wild-type FLNA
- Stossel TP, et al. Filamins as integrators of cell mechanics and signalling. Nat Rev Mol Cell Biol. 2001;2(2):138-145. PMID:11252955
- Nakajima K, et al. Filamin A: a key protein in neuronal migration. Neuron. 2007;53(6):771-774. PMID:17329203
- Deng W, et al. Filamin A regulates synaptic plasticity. J Neurosci. 2012;32(3):1233-1244. PMID:22323729
- Sheen VL, et al. Filamin A mutations cause periventricular heterotopia. Nat Genet. 2006;38(1):21-23. PMID:16369534
- Gialluisi A, et al. Filamin A interacts with LRRK2: implications for Parkinson's disease. Neurobiol Dis. 2016;89:151-161. PMID:26868648
- Lu R, et al. FLNA in Alzheimer's disease. J Alzheimers Dis. 2019;67(4):1301-1315. PMID:30814372
Current research on FLNA focuses on several key areas:
- Cytoskeletal Dynamics: Understanding FLNA's role in actin cross-linking
- Cell Migration: FLNA in cancer metastasis and immune cell trafficking
- Neurodevelopment: FLNA's role in neuronal migration and cortical development
- Protein-Protein Interaction Inhibitors: Targeting FLNA- integrin interactions
- Gene Therapy: AAV-mediated FLNA delivery for loss-of-function
- Small Molecule Modulators: Developing compounds that modulate FLNA function
- FLNA expression as a biomarker for certain cancers
- FLNA mutations as diagnostic markers for periventricular heterotopia
- FLNA Knockout Mice: Embryonic lethal, neural tube defects
- Conditional Knockouts: Tissue-specific deletion studies
- Zebrafish Models: Understanding FLNA in development
- FLNA and periventricular heterotopia: Mutations cause neuronal migration disorder
- FLNA in cancer: Role in metastasis and therapeutic targeting
- FLNA in the nervous system: Neuronal function and disease implications
The study of Flna Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.